Correction to: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer

File Description SizeFormat 
10.1007%2Fs10549-017-4633-6.pdfPublished version759.6 kBAdobe PDFDownload
Title: Correction to: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer
Author(s): Asaduzzaman, M
Constantinou, S
Min, H
Gallon, J
Lin, M-L
Singh, P
Raguz, S
Ali, S
Shousha, S
Charles Coombes, R
Lam, EW-F
Hu, Y
Yagüe, E
Item Type: Journal Article
Abstract: In the original publication, Fig. 1 depicting the blot for EP300 in CAL51 cells (Fig. 1c) was unintentionally duplicated with that from MDA-MB-231 cells (Fig. 1d). The new figure given in this erratum depicts the correct EP300 blot in Fig. 1c.
Publication Date: 5-Jan-2018
Date of Acceptance: 13-Mar-2017
URI: http://hdl.handle.net/10044/1/57000
DOI: https://dx.doi.org/10.1007/s10549-017-4633-6
ISSN: 0167-6806
Publisher: Springer Verlag
Start Page: 605
End Page: 606
Journal / Book Title: Breast Cancer Research and Treatment
Volume: 167
Issue: 2
Sponsor/Funder: Breast Cancer Research Trust
Funder's Grant Number: PC2889BCRT
Copyright Statement: © Springer Science+Business Media, LLC, part of Springer Nature 2018.
Keywords: Science & Technology
Life Sciences & Biomedicine
Oncology
1112 Oncology And Carcinogenesis
Oncology & Carcinogenesis
Publication Status: Published
Appears in Collections:Division of Surgery
Division of Cancer
Department of Medicine
Faculty of Medicine



Items in Spiral are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commons